ING Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,600
| Closed | -$16.3K | – | 654 |
|
2023
Q3 | $16.3K | Hold |
1,600
| – | – | ﹤0.01% | 582 |
|
2023
Q2 | $12K | Hold |
1,600
| – | – | ﹤0.01% | 521 |
|
2023
Q1 | $14.2K | Buy |
+1,600
| New | +$14.2K | ﹤0.01% | 615 |
|
2019
Q3 | – | Sell |
-46,470
| Closed | -$429K | – | 723 |
|
2019
Q2 | $429K | Buy |
46,470
+23,500
| +102% | +$217K | 0.01% | 561 |
|
2019
Q1 | $360K | Buy |
22,970
+4,000
| +21% | +$62.7K | 0.01% | 551 |
|
2018
Q4 | $293K | Sell |
18,970
-4,500
| -19% | -$69.5K | 0.01% | 591 |
|
2018
Q3 | $506K | Buy |
23,470
+6,890
| +42% | +$149K | 0.01% | 507 |
|
2018
Q2 | $403K | Buy |
16,580
+6,000
| +57% | +$146K | 0.01% | 525 |
|
2018
Q1 | $181K | Sell |
10,580
-11,300
| -52% | -$193K | ﹤0.01% | 693 |
|
2017
Q4 | $415K | Sell |
21,880
-3,150
| -13% | -$59.7K | 0.01% | 552 |
|
2017
Q3 | $441K | Sell |
25,030
-25,990
| -51% | -$458K | 0.01% | 537 |
|
2017
Q2 | $1.7M | Sell |
51,020
-2,000
| -4% | -$66.4K | 0.03% | 240 |
|
2017
Q1 | $1.7M | Buy |
+53,020
| New | +$1.7M | 0.03% | 273 |
|
2016
Q4 | – | Sell |
-6,030
| Closed | -$279K | – | 604 |
|
2016
Q3 | $279K | Buy |
6,030
+480
| +9% | +$22.2K | ﹤0.01% | 511 |
|
2016
Q2 | $279K | Hold |
5,550
| – | – | ﹤0.01% | 447 |
|
2016
Q1 | $297K | Hold |
5,550
| – | – | ﹤0.01% | 453 |
|
2015
Q4 | $364K | Hold |
5,550
| – | – | ﹤0.01% | 591 |
|
2015
Q3 | $313K | Hold |
5,550
| – | – | ﹤0.01% | 530 |
|
2015
Q2 | $328K | Sell |
5,550
-10,000
| -64% | -$591K | ﹤0.01% | 588 |
|
2015
Q1 | $969K | Hold |
15,550
| – | – | ﹤0.01% | 598 |
|
2014
Q4 | $894K | Sell |
15,550
-12,000
| -44% | -$690K | ﹤0.01% | 592 |
|
2014
Q3 | $1.48M | Hold |
27,550
| – | – | 0.01% | 493 |
|
2014
Q2 | $1.44M | Sell |
27,550
-54,214
| -66% | -$2.84M | 0.01% | 494 |
|
2014
Q1 | $4.32M | Buy |
81,764
+65,532
| +404% | +$3.46M | 0.02% | 390 |
|
2013
Q4 | $651K | Sell |
16,232
-10,581
| -39% | -$424K | ﹤0.01% | 590 |
|
2013
Q3 | $1.01M | Buy |
26,813
+9,788
| +57% | +$370K | 0.01% | 565 |
|
2013
Q2 | $667K | Buy |
+17,025
| New | +$667K | ﹤0.01% | 582 |
|